Literature DB >> 22976262

A combination of vitamin C and losartan for cisplatin-induced nephrotoxicity in rats.

Farzaneh Ashrafi1, Mehdi Nematbakhsh, Tahereh Safari, Ardeshir Talebi, Hamid Nasri, Mehdi Khazaei, Mohammad-Mehdi Baradaran-Mahdavi, Amir Jafapisheh, Behrooz Olia, Omid Pirhaji, Sayyed-Javad Hashemi-Nia, Fatemeh Eshraghi, Zahra Pezeshki, Mojgan Mortazavi.   

Abstract

INTRODUCTION: The nephroprotective effect of co-administration of vitamin C and losartan as prophylaxis against cisplatin-induced nephrotoxicity (CIN) was evaluated.
MATERIALS AND METHODS: Co-administration of vitamin C and losartan was compared with losartan (10 mg/kg), vitamin C (250 mg/kg), and placebo in 4 groups of rats with CIN. The prophylactic agents were injected daily for a period of 4 days, and on day 3, a single dose (6 mg/kg) of cisplatin was administrated. The animals were sacrificed 7 days later for pathological examination of the kidneys.
RESULTS: Cisplatin prevented the animals' weight gain. The serum levels of creatinine and blood urea nitrogen increased within the groups with CIN, but no significant difference was observed between the groups. The prophylaxis has no effect on serum osmolality, total protein, or nitrite concentrations. The kidney tissue damage was scored, and losartan provided a lower damage score than vitamin C and a combination of vitamin C and losartan.
CONCLUSIONS: We concluded that co-administration of vitamin C and losartan was not more effective than the administration of vitamin C or losartan alone.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22976262

Source DB:  PubMed          Journal:  Iran J Kidney Dis        ISSN: 1735-8582            Impact factor:   0.892


  15 in total

1.  Synergistic protective role of ceftriaxone and ascorbic acid against subacute diazinon-induced nephrotoxicity in rats.

Authors:  Mohamed M Abdel-Daim
Journal:  Cytotechnology       Date:  2014-08-24       Impact factor: 2.058

2.  Renoprotective effects of angiotensin receptor blocker and stem cells in acute kidney injury: Involvement of inflammatory and apoptotic markers.

Authors:  Iman O Sherif; Laila A Al-Mutabagani; Anwar M Alnakhli; Mohamed A Sobh; Hoda E Mohammed
Journal:  Exp Biol Med (Maywood)       Date:  2015-03-29

3.  Amelioration of cisplatin-induced nephrotoxicity in rats by triterpenoid saponin of Terminalia arjuna.

Authors:  Iman O Sherif
Journal:  Clin Exp Nephrol       Date:  2014-11-12       Impact factor: 2.801

4.  Protective Role of Angiotensin II Type 1 Receptor Blocker on Short Time Effect of Oleic Acid Induced Lung and Kidney Injury.

Authors:  Ardeshir Talebi; Fatemeh Emami; Reza Biranvand; Zahra Moosavi; Kimia Ramtin; Soheil Sadeghi; Kimia Baghaei; Zahra Lak; Mehdi Nematbakhsh
Journal:  Int J Prev Med       Date:  2021-01-19

5.  Vitamin E, Vitamin C, or Losartan Is Not Nephroprotectant against Cisplatin-Induced Nephrotoxicity in Presence of Estrogen in Ovariectomized Rat Model.

Authors:  Mehdi Nematbakhsh; Zahra Pezeshki; Fatemeh Eshraghi-Jazi; Farzaneh Ashrafi; Hamid Nasri; Ardeshir Talebi; Tahereh Safari; Maryam Haghighi; Azam Mansouri
Journal:  Int J Nephrol       Date:  2012-09-26

6.  Oxytocin alleviates cisplatin-induced renal damage in rats.

Authors:  Oytun Erbas; Huseyin Anil Korkmaz; Fatih Oltulu; Hüeyin Aktug; Altug Yavasoglu; Levent Akman; Volkan Solmaz; Dilek Taskiran
Journal:  Iran J Basic Med Sci       Date:  2014-10       Impact factor: 2.699

7.  Nonpreventive Role of Aerobic Exercise Against Cisplatin-induced Nephrotoxicity in Female Rats.

Authors:  Jalaledin Noroozi; Farzaneh Zeynali; Mehdi Nematbakhsh; Zahra Pezeshki; Ardeshir Talebi
Journal:  Int J Prev Med       Date:  2015-07-08

8.  Angiotensin Type-1 Receptor Blockade May Not Protect Kidney against Cisplatin-Induced Nephrotoxicity in Rats.

Authors:  Roya Rastghalam; Mehdi Nematbakhsh; Mehrnoosh Bahadorani; Fatemeh Eshraghi-Jazi; Ardeshir Talebi; Maryam Moeini; Farzaneh Ashrafi; Soheila Shirdavani
Journal:  ISRN Nephrol       Date:  2014-03-16

9.  The effects of vitamin E and selenium on cisplatin-induced nephrotoxicity in cancer patients treated with cisplatin-based chemotherapy: A randomized, placebo-controlled study.

Authors:  Mehdi Nematbakhsh; Hamid Nasri
Journal:  J Res Med Sci       Date:  2013-07       Impact factor: 1.852

10.  Sex-Related Difference in Nitric Oxide Metabolites Levels after Nephroprotectant Supplementation Administration against Cisplatin-Induced Nephrotoxicity in Wistar Rat Model: The Role of Vitamin E, Erythropoietin, or N-Acetylcysteine.

Authors:  Mehdi Nematbakhsh; Zahra Pezeshki
Journal:  ISRN Nephrol       Date:  2013-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.